Search clinical trials for: ePOCT

Total 63 results

American Academy of Pediatrics
University of North Carolina, Chapel Hill; Thrasher Research Fund; RTI International and other collaborators

Completed

Newborn Heart Rate as a Catalyst for Improved Survival

Stillbirth | Neonatal Resuscitation | Neonatal Respiratory Depression | Neonatal Bradycardia

Congo, The Democratic Republic of the
Tampere University Hospital
Karolinska University Hospital; Aarhus University Hospital; Kuopio University... and other collaborators

Completed

Treatment of Proximal Humeral Fractures (TPHF)

Humeral Fractures, Proximal

Denmark, Sweden, Finland, Estonia
Chinese University of Hong Kong

Recruiting

Treating Patients With Traumatic Chondral Lesions With Autologous Bone Marrow Cells Derived Engineered Tissues - Engineered Osteochondral Tissue (TCL-aMSC-eOCT)

Traumatic Cartilage Injury

Hong Kong
National Cancer Institute (NCI)

Completed

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

Non Hodgkin's Lymphoma | Hodgkin's Disease

United States
University of Palermo

Recruiting

ICT Tools for the Diagnosis of Autoimmune Diseases (ITAMA_CAP)

Celiac Disease

Italy, Malta
Universiteit Antwerpen
University of Liege; Sciensano

Completed

Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19) (CHARMING)

COVID-19 | SARS-CoV-2

Belgium
Centre Scientifique de Monaco
Department of Health Affairs, Monaco

Recruiting

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Buccal Screening Evaluation Using an RT-PCR Assay and a Rapid ELISA Test Among Symptomatic and Asymptomatic Patients (CORDAGES)

COVID-19 | SARS-CoV-2

Monaco
Center for Primary Care and Public Health (Unisante)...
Swiss Tropical & Public Health Institute; Ifakara Health Institute; University... and other collaborators

Recruiting

Dynamic CDSA to Manage Sick Children in Tanzania (DYNAMIC-TZ)

Child Health

Tanzania
Center for Primary Care and Public Health (Unisante)...
Swiss Tropical & Public Health Institute; Ecole Polytechnique Fédérale de Lausanne and other collaborators

Recruiting

Dynamic CDSA to Manage Sick Children in Rwanda (DYNAMIC-RW)

Child Health

Rwanda
Institut fur Diabetes Karlsburg GmbH

Completed

Blood Glucose Monitoring Systems: Discounter Versus Brand

Diabetes Mellitus

Germany
Novartis Pharmaceuticals

Completed

Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects

Atopic Asthma

Germany, Italy, Spain, Netherlands, United Kingdom
Dana-Farber Cancer Institute
Genentech, Inc.

Recruiting

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome

Richter Syndrome

United States
Johann Wolfgang Goethe University Hospital

Completed

Examination of the Time Advantage Between POCT and Conventional Central Laboratory Analysis

Point-of-Care Systems | Blood | Analysis, Event History

Germany
Brainmarc Ltd.

Unknown

Evaluation of Use of Brain Activity Monitoring for Prediction of Migraine Attacks

Migraine

Israel
Memorial University of Newfoundland

Completed

A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIV (APPROACH)

HIV Infections

Canada
Imperial College London
Imperial College Healthcare NHS Trust

Recruiting

Psychological Impact of Pregnancy of Unknown Location (SOUL)

Anxiety | Ectopic Pregnancy | Pregnancy of Unknown Location

United Kingdom
National University Hospital, Singapore
Agency for Science, Technology and Research

Recruiting

Real-time Early Detection of Nephrotoxicity by Urinary Biomarker Analysis With SeroFlow Technology (RenaFAST)

Acute Kidney Injury

Singapore
Prof. Dr. Michael Christ
Roche Pharma AG; Jena University Hospital; City Hospital Fürth; Bayrisches Rotes... and other collaborators

Terminated

The Triple A Initiative Study ("Aktionsbündnis Akute Atemnot")

Heart Failure | Dyspnea

Germany
Seoul National University Hospital

Completed

Can the Point-Of-Care Chemistry Test (POCT) Solve the Emergency Department (ED) Crowding? (POCTED)

Crowding

Korea, Republic of
Nordic Lymphoma Group
Helsinki University Central Hospital; Aarhus University Hospital

Recruiting

Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis (Bio-CHIC)

Lymphoma, Large B-Cell, Diffuse

Denmark, Norway, Sweden, Finland
Duke University

Withdrawn

Point of Care Testing to Improve Monitoring of LVAD Patients

Anticoagulation and Thrombosis Point of Care Test (AT-POCT)

United States
Rigshospitalet, Denmark
National Center of Cardiology and Internal Medicine named after academician... and other collaborators

Completed

CRP for Respiratory Diagnosis in Kyrgyz Pediatric Practice (COORDINATE)

Respiratory Tract Infections | Antibiotic Resistance | Pediatric Infectious Disease | CRP

Kyrgyzstan
Institute of Hematology & Blood Diseases Hospital
Xian-Janssen Pharmaceutical Ltd.

Not yet recruiting

R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL (BDHRT001)

Richter Transformation

China
Merck Sharp & Dohme LLC

Completed

A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)

Obesity
National Cancer Institute (NCI)

Active, not recruiting

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Burkitt Lymphoma | Primary Mediastinal Large B-cell Lymphoma | Gray Zone Lymphoma | Diffuse Large B-Cell Lymphoma (DLBCL) | Anaplastic Large-Cell Lymphoma

United States
University Hospital Tuebingen
Heart and Diabetes Center North Rhine-Westphalia

Unknown

Specific PoC Testing of Coagulation in Patients Treated With DOAC 1 (SPOCT-DOAC 1)

Anticoagulation With NOAC

Germany
National Cancer Institute (NCI)

Completed

EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma

AIDS Related Lymphoma | AIDS-Associated Lymphoma

United States
Elena N.Parovichnikova

Recruiting

R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)

Lymphoma, High-Grade

Russian Federation
Swiss Tropical & Public Health Institute
Swiss National Science Foundation

Completed

Electronic Algorithms Based on Host Biomarkers to Manage Febrile Children (e-POCT)

Acute Febrile Illness

Tanzania
Astellas Pharma Inc

Recruiting

Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

Rheumatoid Arthritis (RA)

Japan
Shandong Provincial Hospital

Recruiting

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Mantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | B-cell NonHodgkin Lymphoma

China
Stichting Hemato-Oncologie voor Volwassenen Nederland

Active, not recruiting

DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL (HO152)

Lymphoma, B-Cell | Non Hodgkin Lymphoma | High-grade B-cell Lymphoma | MYC Translocation | BCL-2 Translocation

Netherlands, Belgium
Fudan University

Terminated

Dose-adjusted EPOCH-R in MYC Positive DLBCL

Diffuse Large B-cell Lymphoma

China
Pharmacyclics LLC.
Celgene Corporation

Completed

Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma Relapsed

United States
Eastern Health, Canada

Not yet recruiting

18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography

Oncology | Adverse Event | Solitary Pulmonary Nodule | 18F-2-fluoro-2-deoxy-D-glucose
National Cancer Institute (NCI)

Active, not recruiting

Treatment and Natural History Study of Lymphomatoid Granulomatosis

Lymphomatoid Granulomatosis | Non-Hodgkins Lymphoma | Lymphoproliferative Disorder | Granulomatosis, Lymphomatoid

United States
Norwegian University of Science and Technology
University of Oslo; Kathmandu University School of Medical Sciences; Universiteit...

Not yet recruiting

Point-of-care Tests for Vaginal Discharge in Nepal (POCT-BRA)

Sexually Transmitted Diseases | Vaginal Discharge
St. Boniface Hospital
Agriculture and Agri-Food Canada

Active, not recruiting

Effects of Barley on Glucose Control

Healthy

Canada
National Cancer Institute (NCI)

Completed

EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma

Mantle Cell Lymphoma | Lymphoma, Mantle Cell

United States
National Cancer Institute (NCI)

Completed

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

Burkitt Lymphoma | Plasmablastic Lymphoma | Diffuse Large B-cell Lymphoma, c-MYC Positive

United States
National Cancer Institute (NCI)

Recruiting

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma | Non-Hodgkin's Lymphoma | NHL | DLBCL

United States
National Cancer Institute (NCI)

Recruiting

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Acute Leukemia | Myelodysplastic Syndrome

United States
Shandong Provincial Hospital

Recruiting

Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

China
Royal Marsden NHS Foundation Trust
Imperial College London; Institute of Cancer Research, United Kingdom; RM Partners...

Recruiting

The Man Van Project (MV)

Smoking | Alcoholism | Urologic Diseases | Hypertension | Diabetes | Prostate Cancer | Bladder Cancer | Renal Cancer | Urologic Cancer | Mental Health Issue | Testis Cancer

United Kingdom
University Hospital, Basel, Switzerland
ETH Zurich Department for Biosystems, Science and Engineering; Kanton Basel-...

Recruiting

COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)

Coronavirus Infectious Disease 2019 (COVID-19)

Switzerland
National Research Center for Hematology, Russia
National Research Center for Hematology

Recruiting

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Diffuse Large B-Cell Lymphoma

Russian Federation
Brainmarc Ltd.

Completed

Evaluation of Use of Brain Activity Monitoring Dynamics in ADHD

ADHD

Israel
National Cancer Institute (NCI)

Terminated

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Leukemia | Multiple Myeloma | MDS | Non-Hodgkins Lymphoma | Hodgkins Lymphoma

United States
Ontario Clinical Oncology Group (OCOG)
Hoffmann-La Roche

Completed

A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL (CATCH)

HIV Infections | Lymphoma, AIDS Related

Canada
Baylor College of Medicine
National Cancer Institute (NCI)

Completed

Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies (DA-EPOCH-R)

Diffuse Large B Cell Lymphoma | Post Transplant Lymphoproliferative Disorder | Primary Mediastinal (Thymic) Large B-cell Lymphoma

United States

Search clinical trials for: ePOCT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations